FDA Drug Application (021402) for SYNTHROID by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021402
Product Number001
FormTABLET;ORAL
Dosage0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1,AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSYNTHROID
Active IngredientLEVOTHYROXINE SODIUM



Back to FDA Applications sponsored by ABBVIE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.